Two cases of circulatory collapse due to suspected remimazolam anaphylaxis

BACKGROUND: Remimazolam was approved in Japan in January 2020. We report two cases of circulatory collapse due to suspected remimazolam anaphylaxis during anesthetic induction. CASE PRESENTATION: Case 1: A 74-year-old male was scheduled for debridement and skin grafting for a severe burn injury. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Satoshi, Takekawa, Daiki, Kitayama, Masato, Hirota, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898805/
https://www.ncbi.nlm.nih.gov/pubmed/35249154
http://dx.doi.org/10.1186/s40981-022-00508-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898805/
https://www.ncbi.nlm.nih.gov/pubmed/35249154
http://dx.doi.org/10.1186/s40981-022-00508-5

Ejemplares similares